KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elevance Health (ELV) Invested Capital (2016 - 2025)

Elevance Health (ELV) has disclosed Invested Capital for 17 consecutive years, with $44.1 billion as the latest value for Q3 2025.

  • On a quarterly basis, Invested Capital changed 0.46% to $44.1 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $44.1 billion, a 0.46% change, with the full-year FY2024 number at $72.2 billion, up 12.22% from a year prior.
  • Invested Capital was $44.1 billion for Q3 2025 at Elevance Health, up from $43.9 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $72.3 billion in Q1 2025 to a low of $33.9 billion in Q1 2021.
  • A 5-year average of $49.8 billion and a median of $43.9 billion in 2024 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: surged 75.96% in 2023, then plummeted 32.98% in 2024.
  • Elevance Health's Invested Capital stood at $58.9 billion in 2021, then rose by 2.18% to $60.2 billion in 2022, then increased by 6.85% to $64.3 billion in 2023, then grew by 12.22% to $72.2 billion in 2024, then plummeted by 38.87% to $44.1 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Invested Capital are $44.1 billion (Q3 2025), $43.9 billion (Q2 2025), and $72.3 billion (Q1 2025).